Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$981M |
| 2 |
Apple
AAPL
|
+$704M |
| 3 |
Amazon
AMZN
|
+$670M |
| 4 |
Merck
MRK
|
+$431M |
| 5 |
NVIDIA
NVDA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$441M |
| 2 |
JD.com
JD
|
+$196M |
| 3 |
Aon
AON
|
+$184M |
| 4 |
VER
VEREIT, Inc.
VER
|
+$165M |
| 5 |
Dell
DELL
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.25% |
| 3 | Financials | 13.01% |
| 4 | Consumer Discretionary | 11.99% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Nature's Sunshine
NATR
$354M
| $3.91M | ﹤0.01% |
211,529
-34,833
| -14% | -$591K |
|
3027
Quince Therapeutics
QNCX
$28.8M
| $3.91M | ﹤0.01% |
1,548
-101
| -6% | -$616K |
|
3028
Alaunos Therapeutics
TCRT
$4.84M
| $3.9M | ﹤0.01% |
23,870
+1,606
| +7% | +$353K |
|
|
IMGO
3029
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $3.9M | ﹤0.01% |
164,613
+19,799
| +14% | +$459K |
|
|
AHT
3030
Ashford Hospitality Trust
AHT
$20.9M
| $3.9M | ﹤0.01% |
40,614
+6,802
| +20% | +$848K |
|
|
CBAY
3031
DELISTED
Cymabay Therapeutics
CBAY
| $3.89M | ﹤0.01% |
1,151,205
+44,114
| +4% | +$167K |
|
3032
Cardiff Oncology
CRDF
$74.1M
| $3.88M | ﹤0.01% |
645,084
+62,927
| +11% | +$375K |
|
3033
UBS Group
UBS
$176B
| $3.87M | ﹤0.01% |
216,831
-3,308
| -2% | -$58.2K |
|
|
DOO
3034
Bombardier Recreational Products
DOO
$4.86B
| $3.87M | ﹤0.01% |
44,133
+299
| +0.7% | +$26K |
|
3035
Paymentus
PAY
$5.08B
| $3.87M | ﹤0.01% |
110,537
+39,859
| +56% | +$1.1M |
|
3036
Future Fuel
FF
$216M
| $3.86M | ﹤0.01% |
505,170
+55,150
| +12% | +$428K |
|
3037
Greif Class B
GEF.B
$4.25B
| $3.85M | ﹤0.01% |
64,442
-7,817
| -11% | -$503K |
|
3038
dLocal
DLO
$4.49B
| $3.85M | ﹤0.01% |
107,846
+748
| +0.7% | +$32.3K |
|
3039
eGain
EGAN
$198M
| $3.84M | ﹤0.01% |
385,147
+5,186
| +1% | +$53.8K |
|
3040
Evolus
EOLS
$401M
| $3.83M | ﹤0.01% |
588,800
+14,363
| +3% | +$98.5K |
|
3041
Shattuck Labs
STTK
$714M
| $3.83M | ﹤0.01% |
450,189
+18,746
| +4% | +$258K |
|
3042
Fresenius Medical Care
FMS
$12.8B
| $3.8M | ﹤0.01% |
117,210
-10,715
| -8% | -$353K |
|
3043
First Bank
FRBA
$468M
| $3.8M | ﹤0.01% |
261,736
-3,129
| -1% | -$46.5K |
|
|
DRRX
3044
DELISTED
DURECT Corp
DRRX
| $3.79M | ﹤0.01% |
385,026
-2,319
| -0.6% | -$25.6K |
|
|
NMTR
3045
DELISTED
9 Meters Biopharma
NMTR
| $3.78M | ﹤0.01% |
193,238
+12,035
| +7% | +$269K |
|
3046
Petrobras
PBR
$119B
| $3.76M | ﹤0.01% |
342,694
+554
| +0.2% | +$5.85K |
|
|
TRML
3047
DELISTED
Tourmaline Bio
TRML
| $3.76M | ﹤0.01% |
24,582
+7,448
| +43% | +$1.1M |
|
3048
Innovative Industrial Properties
IIPR
$1.69B
| $3.75M | ﹤0.01% |
14,279
+693
| +5% | +$178K |
|
3049
Donegal Group Class A
DGICA
$727M
| $3.74M | ﹤0.01% |
261,959
+6,560
| +3% | +$94.1K |
|
|
ZEUS
3050
DELISTED
Olympic Steel
ZEUS
| $3.74M | ﹤0.01% |
159,110
+646
| +0.4% | +$15.6K |
|
Similar funds
Geode Capital Management's Q4 2021 Portfolio in Review
As of Q4 2021, Geode Capital Management held 5,071 positions worth $830B, up 12% from $743B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q4 2021 filing shows 216 new, 2,976 increased, 1,070 reduced and 95 closed positions. Its largest new stake was Rivian: 2,078,098 shares worth $215M. The largest sale was Kansas City Southern, an estimated $441M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2021 buy was Rivian: 2,078,098 shares worth $215M.
- Geode Capital Management added most to Microsoft in Q4 2021, an estimated $981M increase.
- Geode Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $196M.
- Geode Capital Management fully exited Kansas City Southern in Q4 2021, selling an estimated $441M.
- Geode Capital Management's ten largest holdings make up 24% of its $830B portfolio in Q4 2021.
- Geode Capital Management opened 216 new positions and closed 95 in Q4 2021.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $830B.
Based on Geode Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.